{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T06:11:30Z","timestamp":1784614290604,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T00:00:00Z","timestamp":1542585600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Osteoporos"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s11657-018-0542-5","type":"journal-article","created":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T06:57:41Z","timestamp":1542610661000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["FRAX\u00ae based intervention thresholds for management of osteoporosis in Singaporean women"],"prefix":"10.1007","volume":"13","author":[{"given":"M.","family":"Chandran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. V.","family":"McCloskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. P. P.","family":"Thu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Logan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Tay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. C.","family":"Ang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. K. K.","family":"Aung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. S.","family":"Choo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. X.","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X. F.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X. M.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. L.","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Lekamwasam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,19]]},"reference":[{"key":"542_CR1","unstructured":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis (1994) Report of a WHO Study Group. World Health Organ Tech Rep Ser 843:1\u2013129"},{"issue":"8","key":"542_CR2","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1007\/s00198-007-0343-y","volume":"18","author":"JA Kanis","year":"2007","unstructured":"Kanis JA, Oden A, Johnell O, Johansson H, De Laet C, Brown J et al (2007) The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 18(8):1033\u20131046. \n                    https:\/\/doi.org\/10.1007\/s00198-007-0343-y","journal-title":"Osteoporos Int"},{"issue":"11","key":"542_CR3","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1136\/annrheumdis-2015-207907","volume":"74","author":"A Marques","year":"2015","unstructured":"Marques A, Ferreira RJO, Santos E, Loza E, Carmona L, da Silva JAP et al (2015) The accuracy of osteoporotic fracture risk prediction tools: a systematic review and meta-analysis. Ann Rheum Dis 74(11):1958\u20131967. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2015-207907","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"542_CR4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11657-017-0324-5","volume":"12","author":"J Compston","year":"2017","unstructured":"Compston J, Cooper A, Cooper C, Gittoes N, Gregson C, Harvey N et al (2017) UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos 12(1):43","journal-title":"Arch Osteoporos"},{"issue":"Suppl 4","key":"542_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/EP161435.GL","volume":"22","author":"PM Camacho","year":"2016","unstructured":"Camacho PM, Petak SM, Binkley N, Clarke BL, Harris ST, Hurley DL, Kleerekoper M, Lewiecki EM, Miller PD, Narula HS, Pessah-Pollack R, Tangpricha V, Wimalawansa SJ, Watts NB (2016) American association of clinical endocrinologists and American college of endocrinology clinical practice guidelines for the Diagnosis and treatment of postmenopausal osteoporosis - 2016. Endocr Pract 22(Suppl 4):1\u201342. \n                    https:\/\/doi.org\/10.4158\/EP161435.GL","journal-title":"Endocr Pract"},{"issue":"10","key":"542_CR6","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","volume":"25","author":"F Cosman","year":"2014","unstructured":"Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S et al (2014) Clinician\u2019s guide to prevention and treatment of osteoporosis. Osteoporos Int 25(10):2359\u20132381. \n                    https:\/\/doi.org\/10.1007\/s00198-014-2794-2","journal-title":"Osteoporos Int"},{"issue":"5","key":"542_CR7","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1210\/jc.2004-1568","volume":"90","author":"SA Wainwright","year":"2005","unstructured":"Wainwright SA, Marshall LM, Ensrud KE, Cauley JA, Black DM, Hillier TA, Hochberg MC, Vogt MT, Orwoll ES (2005) Hip fracture in women without osteoporosis. J Clin Endocrinol Metab 90(5):2787\u20132793. \n                    https:\/\/doi.org\/10.1210\/jc.2004-1568","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"542_CR8","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00198-004-1780-5","volume":"16","author":"JA Kanis","year":"2005","unstructured":"Kanis JA, Borgstrom F, De Laet C, Johansson H, Johnell O, Jonsson B et al (2005) Assessment of fracture risk. Osteoporos Int 16(6):581\u2013589. \n                    https:\/\/doi.org\/10.1007\/s00198-004-1780-5","journal-title":"Osteoporos Int"},{"issue":"10122","key":"542_CR9","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S0140-6736(17)32640-5","volume":"391","author":"L Shepstone","year":"2018","unstructured":"Shepstone L, Lenaghan E, Cooper C, Clarke S, Fong-Soe-Khioe R, Fordham R et al (2018) Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial. Lancet (London, England) 391(10122):741\u2013747. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(17)32640-5","journal-title":"Lancet (London, England)"},{"issue":"7","key":"542_CR10","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1002\/jbmr.1606","volume":"27","author":"EV McCloskey","year":"2012","unstructured":"McCloskey EV, Johansson H, Oden A, Austin M, Siris E, Wang A et al (2012) Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX. J Bone Miner Res 27(7):1480\u20131486. \n                    https:\/\/doi.org\/10.1002\/jbmr.1606","journal-title":"J Bone Miner Res"},{"key":"542_CR11","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1007\/s00198-011-1869-6","volume":"23","author":"K Lippuner","year":"2012","unstructured":"Lippuner K, Johansson H, Borgstr\u00f6m F, Kanis JA, Rizzoli R (2012) Cost-effective intervention thresholds against osteoporotic fractures based on FRAX\u00ae in Switzerland. Osteoporos Int 23:2579\u20132589. \n                    https:\/\/doi.org\/10.1007\/s00198-011-1869-6","journal-title":"Osteoporos Int"},{"issue":"2","key":"542_CR12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s12020-013-0076-y","volume":"45","author":"Z Zhang","year":"2014","unstructured":"Zhang Z, Ou Y, Sheng Z, Liao E (2014) How to decide intervention thresholds based on FRAX in central south Chinese postmenopausal women. Endocrine 45(2):195\u2013197. \n                    https:\/\/doi.org\/10.1007\/s12020-013-0076-y","journal-title":"Endocrine"},{"issue":"4","key":"542_CR13","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00198-007-0550-6","volume":"19","author":"ANA Tosteson","year":"2008","unstructured":"Tosteson ANA, Melton LJ, Dawson-Hughes B, Baim S, Favus MJ, Khosla S et al (2008) Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int 19(4):437\u2013447. \n                    https:\/\/doi.org\/10.1007\/s00198-007-0550-6","journal-title":"Osteoporos Int"},{"issue":"10","key":"542_CR14","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1007\/s00198-008-0712-1","volume":"19","author":"JA Kanis","year":"2008","unstructured":"Kanis JA, McCloskey EV, Johansson H, Strom O, Borgstrom F, Oden A et al (2008) Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK. Osteoporos Int 19(10):1395\u20131408. \n                    https:\/\/doi.org\/10.1007\/s00198-008-0712-1","journal-title":"Osteoporos Int"},{"issue":"1","key":"542_CR15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00198-016-3766-5","volume":"28","author":"M Chakhtoura","year":"2017","unstructured":"Chakhtoura M, Leslie WD, McClung M, Cheung AM, Fuleihan GEH (2017) The FRAX-based Lebanese osteoporosis treatment guidelines: rationale for a hybrid model. Osteoporos Int 28(1):127\u2013137. \n                    https:\/\/doi.org\/10.1007\/s00198-016-3766-5","journal-title":"Osteoporos Int"},{"issue":"3","key":"542_CR16","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s00198-013-2553-9","volume":"25","author":"E Cheung","year":"2014","unstructured":"Cheung E, Cheung CL, Kung AWC, Tan KCB (2014) Possible FRAX-based intervention thresholds for a cohort of Chinese postmenopausal women. Osteoporos Int 25(3):1017\u20131023. \n                    https:\/\/doi.org\/10.1007\/s00198-013-2553-9","journal-title":"Osteoporos Int"},{"key":"542_CR17","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s11657-013-0148-x","volume":"8","author":"S Lekamwasam","year":"2013","unstructured":"Lekamwasam S (2013) Sri Lankan FRAX model and country-specific intervention thresholds. Arch Osteoporos 8:148","journal-title":"Arch Osteoporos"},{"key":"542_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11657-012-0109-9","volume":"7","author":"H Orimo","year":"2012","unstructured":"Orimo H, Nakamura T, Hosoi T, Iki M, Uenishi K, Endo N, Ohta H, Shiraki M, Sugimoto T, Suzuki T, Soen S, Nishizawa Y, Hagino H, Fukunaga M, Fujiwara S (2012) Japanese 2011 guidelines for prevention and treatment of osteoporosis--executive summary. Arch Osteoporos 7:3\u201320. \n                    https:\/\/doi.org\/10.1007\/s11657-012-0109-9","journal-title":"Arch Osteoporos"},{"issue":"1\u20132","key":"542_CR19","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s11657-012-0097-9","volume":"7","author":"D Korthoewer","year":"2012","unstructured":"Korthoewer D, Chandran M, Endocrine and Metabolic Society of Singapore (2012) Osteoporosis management and the utilization of FRAX\u00ae: a survey amongst health care professionals of the Asia-Pacific. Arch Osteoporos 7(1\u20132):193\u2013200","journal-title":"Arch Osteoporos"},{"issue":"2","key":"542_CR20","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1093\/ije\/dyx278","volume":"47","author":"WPP Thu","year":"2018","unstructured":"Thu WPP, Logan SJS, Lim CW, Wang YL, Cauley JA, Yong EL et al (2018) Cohort profile: the Integrated Women\u2019s Health Programme (IWHP): a study of key health issues of midlife Singaporean women. Int J Epidemiol 47(2):389\u2013390f. \n                    https:\/\/doi.org\/10.1093\/ije\/dyx278","journal-title":"Int J Epidemiol"},{"issue":"1","key":"542_CR21","first-page":"25","volume":"38","author":"KH Leong","year":"1997","unstructured":"Leong KH, Feng PH (1997) Bone mineral density measurements using the Hologic QD2000 in 175 Singaporean women aged 20\u201380. Singap Med J 38(1):25\u201326","journal-title":"Singap Med J"},{"issue":"8","key":"542_CR22","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1038\/ijo.2011.185","volume":"36","author":"H Gao","year":"2012","unstructured":"Gao H, Salim A, Lee J, Tai ES, van Dam RM (2012) Can body fat distribution, adiponectin levels and inflammation explain differences in insulin resistance between ethnic Chinese, Malays and Asian Indians? Int J Obes 36(8):1086\u20131093. \n                    https:\/\/doi.org\/10.1038\/ijo.2011.185","journal-title":"Int J Obes"},{"issue":"6","key":"542_CR23","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1186\/cc3000","volume":"8","author":"V Bewick","year":"2004","unstructured":"Bewick V, Cheek L, Ball J (2004) Statistics review 13: receiver operating characteristic curves. Crit Care 8(6):508\u2013512. \n                    https:\/\/doi.org\/10.1186\/cc3000","journal-title":"Crit Care"},{"issue":"1","key":"542_CR24","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","volume":"3","author":"WJ YOUDEN","year":"1950","unstructured":"YOUDEN WJ (1950) Index for rating diagnostic tests. Cancer 3(1):32\u201335. \n                    https:\/\/doi.org\/10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","journal-title":"Cancer"},{"issue":"8","key":"542_CR25","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1007\/s00198-015-3176-0","volume":"26","author":"E McCloskey","year":"2015","unstructured":"McCloskey E, Kanis JA, Johansson H, Harvey N, Od\u00e9n A, Cooper A, Cooper C, Francis RM, Reid DM, Marsh D, Selby P, Thompson F, Hewitt S, Compston J (2015) FRAX-based assessment and intervention thresholds--an exploration of thresholds in women aged 50 years and older in the UK. Osteoporos Int 26(8):2091\u20132099. \n                    https:\/\/doi.org\/10.1007\/s00198-015-3176-0","journal-title":"Osteoporos Int"},{"issue":"1","key":"542_CR26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00198-012-2074-y","volume":"24","author":"JA Kanis","year":"2013","unstructured":"Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster JY et al (2013) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 24(1):23\u201357. \n                    https:\/\/doi.org\/10.1007\/s00198-012-2074-y","journal-title":"Osteoporos Int"},{"issue":"4","key":"542_CR27","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s001980170121","volume":"12","author":"LK Koh","year":"2001","unstructured":"Koh LK, Saw SM, Lee JJ, Leong KH, Lee J, National Working Committee on Osteoporosis et al (2001) Hip fracture incidence rates in Singapore 1991\u20131998. Osteoporos Int 12(4):311\u2013318. \n                    https:\/\/doi.org\/10.1007\/s001980170121","journal-title":"Osteoporos Int"},{"issue":"11","key":"542_CR28","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1007\/s00198-011-1632-z","volume":"22","author":"JA Kanis","year":"2011","unstructured":"Kanis JA, Bianchi G, Bilezikian JP, Kaufman JM, Khosla S, Orwoll E, Seeman E (2011) Towards a diagnostic and therapeutic consensus in male osteoporosis. Osteoporos Int 22(11):2789\u20132798. \n                    https:\/\/doi.org\/10.1007\/s00198-011-1632-z","journal-title":"Osteoporos Int"},{"issue":"4 Suppl B","key":"542_CR29","first-page":"S1","volume":"18","author":"S Levis","year":"2012","unstructured":"Levis S, Theodore G (2012) Summary of AHRQ\u2019s comparative effectiveness review of treatment to prevent fractures in men and women with low bone density or osteoporosis: update of the 2007 report. J Manag Care Pharm 18(4 Suppl B):S1\u2013S15 discussion S13","journal-title":"J Manag Care Pharm"},{"key":"542_CR30","doi-asserted-by":"publisher","first-page":"g4120","DOI":"10.1136\/bmj.g4120","volume":"349","author":"KE Ensrud","year":"2014","unstructured":"Ensrud KE, Taylor BC, Peters KW, Gourlay ML, Donaldson MG, Leslie WD et al (2014) Implications of expanding indications for drug treatment to prevent fracture in older men in United States: cross sectional and longitudinal analysis of prospective cohort study. BMJ 349:g4120","journal-title":"BMJ"},{"issue":"5","key":"542_CR31","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/j.1524-4733.2004.75003.x","volume":"7","author":"HG Eichler","year":"2004","unstructured":"Eichler HG, Kong SX, Gerth WC, Mavros P, J\u00f6nsson B (2004) Use of cost-effectiveness analysis in health-care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge? Value Health 7(5):518\u2013528. \n                    https:\/\/doi.org\/10.1111\/j.1524-4733.2004.75003.x","journal-title":"Value Health"},{"issue":"7","key":"542_CR32","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1007\/s00198-018-4505-x","volume":"29","author":"NC Harvey","year":"2018","unstructured":"Harvey NC, McCloskey E, Kanis JA, Compston J, Cooper C (2018) Cost-effective but clinically inappropriate: new NICE intervention thresholds in osteoporosis (Technology Appraisal 464). Osteoporos Int 29(7):1511\u20131513. \n                    https:\/\/doi.org\/10.1007\/s00198-018-4505-x","journal-title":"Osteoporos Int"}],"container-title":["Archives of Osteoporosis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11657-018-0542-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-018-0542-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-018-0542-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T00:30:34Z","timestamp":1574123434000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11657-018-0542-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,19]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["542"],"URL":"https:\/\/doi.org\/10.1007\/s11657-018-0542-5","relation":{},"ISSN":["1862-3522","1862-3514"],"issn-type":[{"value":"1862-3522","type":"print"},{"value":"1862-3514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,19]]},"assertion":[{"value":"27 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"130"}}